And we are off and running at Asembia 2025. If you would like to talk market access, product reimbursement, or patient assistance, the Real Endpoints team still has some open spots to meet April 27, 28, and 29. Connect with us via a direct message or email @info@realendpoints.com.
read full article ›This month brought a wave of healthcare news—from leadership changes at HHS and FDA staff reductions to the finalized Medicare Advantage rule and ongoing concerns around pharmaceutical tariffs. Amid the shifting landscape, one issue remains consistent: many patients continue to face high out-of-pocket drug costs. According to the Commonwealth Fund, 43% of working adults are under-insured, and nearly half of Medicare beneficiaries struggle with co-pays. Solutions like RE Assist, an AI-supported platform and 2024 Fierce Healthcare Innovation awardee, aim to help address this gap by connecting patients with financial support resources.
read full article ›Thanks to LifeScience ORG for the opportunity for Real Endpoints' Jeff Berkowitz to talk about US market access and payer trends with Gregory Oakes!
read full article ›Super excited that our Real Endpoints team will be onsite at to discuss supporting patient access and our award-winning platform RE Assist.
read full article ›We are so excited to welcome Emma Frohnapfel to Real Endpoints as a Client Service Manager! Emma brings a wealth of data and operational expertise from her training at Clemson University, her ongoing graduate studies, and past internships. She will be a critical resource supporting a range of projects spanning our patient support work and more bespoke projects linked to market access.
read full article ›RFK Jr. said "everything is on the table" when it comes to how HHS will make America healthy again. Here are the top three things we are watching and discussing internally, including what's really required to make America healthy in the first place.
read full article ›Tariffs may seem like a distant economic lever, but in the biopharma industry, their effects could be immediate and far-reaching. From rising drug prices and potential shortages to widening health disparities, the downstream impact could touch every part of the healthcare system—and every patient it serves.
read full article ›We’re excited and honored that Fierce Healthcare named Real Endpoints financial assistance tool RE Assist as the Fierce Healthcare Innovation Award winner in the Financial/Operational Solutions category.
read full article ›Real Endpoints' was privileged to co-host the inaugural Cell Therapy Commercialization Leadership Forum along with Adjuvant Partners and Leavitt Partners with support from McKesson, FFF Enterprises and CIRM.
read full article ›